| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP, Global R&D
1 company
Fridriksdottir Hafrun serves as an Executive VP, Global R&D at TEVA. Across recent SEC filings that breaks down to 0 buys and 29 sells. Those positions are worth an estimated $11K at current prices.
Historically, Fridriksdottir Hafrun's trades have earned a below-average insider score of 47/100 across 7 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -10.6%.
The biggest single holding is TEVA (~$11K) as Executive VP, Global R&D. The recent filings there lean toward selling, a net 379,061 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 29,496 | $12.69 | $374,436.97 | -22.8% | |
| Mar 17, 2020 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 514 | $7.16 | $3,682.04 | -1.1% | |
| Feb 14, 2020 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 11,472 | $12.14 | $139,295.32 | -20.3% | |
| Feb 10, 2020 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 5,544 | $12.27 | $68,024.88 | -14.3% | |
| Dec 31, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 2,459 | $9.92 | $24,396.23 | -9.8% | |
| Dec 2, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 4,310 | $10.49 | $45,214.49 | -17.3% | |
| Mar 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 356 | $16.63 | $5,918.54 | -2.1% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 409 | $16.88 | $6,905.27 | -2.5% | |
| Feb 14, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 1,841 | $17.67 | $32,528.63 | -10.7% | |
| Jan 2, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 1,643 | $15.70 | $25,799.21 | -12.2% |